Table 3. Post-hoc comparison of LIF trials. Values are p <.
| Shin Guards |
Shin Guards |
Max. Force* |
Impulse* |
| Nike Mercurial™ |
Adidas UCL™ |
.000 |
.000 |
| Adidas Predator™ |
.000 |
.000 |
| Carbon-1 (Eva) |
.000 |
.000 |
| Carbon-2 (Neoprene) |
.000 |
.000 |
| Adidas UCL™ |
Nike Mercurial™ |
.000 |
.000 |
| Adidas Predator™ |
n.s. |
n.s. |
| Carbon-1 (Eva) |
.000 |
.000 |
| Carbon-2 (Neoprene) |
.000 |
.000 |
| Adidas Predator™ |
Nike Mercurial™ |
.000 |
.000 |
| Adidas UCL™ |
n.s. |
n.s. |
| Carbon-1 (Eva) |
.000 |
.000 |
| Carbon-2 (Neoprene) |
.000 |
.000 |
| Carbon-1 (Eva) |
Nike Mercurial™ |
.000 |
.000 |
| Adidas UCL™ |
.000 |
.000 |
| Adidas Predator |
.000 |
.000 |
| Carbon-2 (Neoprene) |
n.s. |
n.s. |
| Carbon-2 (Neoprene) |
Nike Mercurial™ |
.000 |
.000 |
| Adidas UCL™ |
.000 |
.000 |
| Adidas Predator™ |
.000 |
.000 |
| Carbon-1 (Eva) |
n.s. |
n.s. |
* Multiple Comparisons, Tukey HSD. n.s. non significant
